TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | -4 | -11 | 14 | 51 | 291 | 57 |
| P | %wins | 0 | 0 | 0 | 100 | 100 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/20 16:43 | 5/13/19 | CRTX | Cortexyme, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ryan Una S | CA | D | P | 49 | 17.00 | 0 | 3 | New | 3 | I | |||||||||||||||
5/11/17 16:05 | 5/10/17 | AMRI | Albany Molecular Research Inc | DE | Health | Biolab | Commercial Physical & Biologi | Ryan Una S | NY | D | M.d | 72 | 14.47 | 19 | 5 | 11 | 52 | D | -6 | 34 | 14 | -3 | 30 | 13 | 8 | 15 | 0 | ||||||
10/6/16 16:30 | 10/5/16 | AMRI | Albany Molecular Research Inc | DE | Health | Biolab | Commercial Physical & Biologi | Ryan Una S | NY | D | M.d | 59 | 11.83 | 5 | 5 | 13 | 43 | D | -25 | -1 | 6 | 24 | 19 | 12 | 6 | 2 | 0 | -2 | -16 | 11 | -22 | ||
5/23/12 11:37 | 5/22/12 | AMRI | Albany Molecular Research Inc | DE | Health | Biolab | Commercial Physical & Biologi | Ryan Una S | NY | D | P | 1 | 2.81 | 0 | 0 | 1 | 14 | D | -57 | -42 | 20 | -4 | 2 | -8 | -6 | -4 | -1 | -4 | -11 | 14 | 51 | 291 | |
8/16/06 16:30 | 8/16/06 | AVAN | Avant Immunotherapeutics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ryan Una S | MA | DO | P,CEO | P | 41 | 1.36 | 0 | 30 | 3 | 899 | D | ||||||||||||||
8/4/04 12:04 | 8/3/04 | AVAN | Avant Immunotherapeutics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ryan Una S | MA | DO | P,CEO | P | 19 | 1.87 | 0 | 10 | 2 | 467 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |